Chemical Structure : SU14813 maleate
CAS No.: 849643-15-8
Catalog No.: PC-42623Not For Human Use, Lab Use Only.
SU14813 maleate is a broad-spectrum RTKs inhibitor with IC50 ranging from 2 to 50 nM for VEGFR-1, VEGFR-2, PDGFRs, KIT, FLT3, and CSF1R/FMS.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $88 | In stock | |
10 mg | $128 | In stock | |
25 mg | $218 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SU14813 maleate is a broad-spectrum RTKs inhibitor with IC50 ranging from 2 to 50 nM for VEGFR-1, VEGFR-2, PDGFRs, KIT, FLT3, and CSF1R/FMS.
SU14813 shows poor activity for EGFR and c-Met in biochemical assays.
SU14813 inhibits VEGFR-2, PDGFR-β, and KIT phosphorylation in porcine aorta endothelial cells with IC50 of 5.2, 9.9, and 11.2 nM respectively.
SU14813 is active in xenograft tumor models.
M.Wt | 558.5554 | |
Formula | C27H31FN4O8 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-(4-morpholinyl)propyl]-2,4-dimethyl-, (2Z)-2-butenedioate (1:1) |
1. Patyna S, et al. Mol Cancer Ther. 2006 Jul;5(7):1774-82.
2. Hu-Lowe D, et al. Mol Cancer Ther. 2011 Nov;10(11):2015.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright